John L. Brottem - 16 May 2023 Form 4 Insider Report for Outset Medical, Inc. (OM)

Signature
John L Brottem
Issuer symbol
OM
Transactions as of
16 May 2023
Net transactions value
-$68,024
Form type
4
Filing time
17 May 2023, 18:26:23 UTC
Previous filing
05 May 2023
Next filing
21 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Sale $26,580 -1,335 -2.2% $19.91 60,262 16 May 2023 Direct F1
transaction OM Common Stock Options Exercise $13,414 +1,415 +2.3% $9.48 61,677 17 May 2023 Direct F2
transaction OM Common Stock Sale $28,413 -1,415 -2.3% $20.08 60,262 17 May 2023 Direct F2
transaction OM Common Stock Sale $26,445 -1,317 -2.2% $20.08 58,945 17 May 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,415 -7.1% $0.000000 18,389 17 May 2023 Common Stock 1,415 $9.48 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.
F3 This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.